NO165073C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6-hydroxyalkyl-2-(substituert)thio-penem-3-carboxylsyrer - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6-hydroxyalkyl-2-(substituert)thio-penem-3-carboxylsyrerInfo
- Publication number
- NO165073C NO165073C NO834331A NO834331A NO165073C NO 165073 C NO165073 C NO 165073C NO 834331 A NO834331 A NO 834331A NO 834331 A NO834331 A NO 834331A NO 165073 C NO165073 C NO 165073C
- Authority
- NO
- Norway
- Prior art keywords
- compound
- preparation
- chem
- hydrogen
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 150000002961 penems Chemical class 0.000 abstract 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 abstract 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 abstract 1
- 241001061127 Thione Species 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 125000000962 organic group Chemical group 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pens And Brushes (AREA)
- Cephalosporin Compounds (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Magnetic Variables (AREA)
- Electroluminescent Light Sources (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/445,295 US4530793A (en) | 1982-11-29 | 1982-11-29 | Processes for the production of penems |
US06/458,511 US4435412A (en) | 1982-11-29 | 1983-01-17 | 5R,6S,8R-2-(1-Methyl-2-imidazolylmethylthio)-6-(1-hydroxyethyl)penem-3-carboxylic acid |
US06/461,845 US4435413A (en) | 1983-01-28 | 1983-01-28 | (5R-6S,8R)-6-(1-Hydroxyethyl)-2-(2-glycylaminoethylthio)-penem-3-carboxylic acid |
US06/462,723 US4456609A (en) | 1983-01-31 | 1983-01-31 | (5R, 6S, 8R-6-(1-Hydroxyethyl)-2-(2-[methylaminocarbonyl]-ethylthio)-penem-3-carboxylic acid |
Publications (3)
Publication Number | Publication Date |
---|---|
NO834331L NO834331L (no) | 1984-05-30 |
NO165073B NO165073B (no) | 1990-09-10 |
NO165073C true NO165073C (no) | 1990-12-19 |
Family
ID=27503921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO834331A NO165073C (no) | 1982-11-29 | 1983-11-25 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6-hydroxyalkyl-2-(substituert)thio-penem-3-carboxylsyrer |
Country Status (14)
Country | Link |
---|---|
EP (2) | EP0345827A1 (de) |
JP (1) | JPH0631254B2 (de) |
KR (1) | KR880002512B1 (de) |
AT (1) | ATE112778T1 (de) |
AU (1) | AU575545B2 (de) |
DE (1) | DE3382761T2 (de) |
DK (1) | DK166152C (de) |
FI (1) | FI834305A (de) |
GR (1) | GR81289B (de) |
HU (1) | HU194889B (de) |
IL (1) | IL70327A0 (de) |
NO (1) | NO165073C (de) |
NZ (1) | NZ206389A (de) |
PT (1) | PT77712B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE28648T1 (de) * | 1982-03-26 | 1987-08-15 | Hoechst Uk Ltd | 7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-derivate |
GB2159519B (en) * | 1982-03-26 | 1986-08-20 | Hoechst Uk Ltd | 7-oxo-4-thia-1-azabicyclo3,2,0heptane derivatives; azetidinones |
EP0320497A1 (de) * | 1983-01-25 | 1989-06-14 | Merck & Co. Inc. | Substituierte 2-Thioxopename, deren Zwischenprodukte und Verfahren zur Herstellung von substituierten 2-Thioxopenamen und 2-substituierten Thiopenemen |
DK141784A (da) * | 1983-03-14 | 1984-09-15 | Schering Corp | Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse |
US4772597A (en) * | 1983-10-14 | 1988-09-20 | Pfizer Inc. | 2-azacycloalkylthiopenem derivatives |
YU44241B (en) * | 1983-10-14 | 1990-04-30 | Pfizer | Process for making derivatives of 2-azacyclothiopenem |
US4584133A (en) * | 1983-11-07 | 1986-04-22 | Schering Corporation | Process for the production of penems |
US4782145A (en) * | 1986-06-02 | 1988-11-01 | Pfizer Inc. | Process for penem derivatives |
US4767853A (en) * | 1986-07-21 | 1988-08-30 | Schering Corporation | Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof |
PH24872A (en) * | 1986-08-25 | 1990-12-26 | Schering Corp | (5r,6s,8r)-6-(-1-hydroxyethyl)-2-(3r-pyrrolidin-2-one-3-yl)thiopenem-3-carboxylic acid |
US4992543A (en) * | 1988-10-19 | 1991-02-12 | Pfizer Inc. | Penem derivatives |
JP2559649B2 (ja) * | 1991-08-30 | 1996-12-04 | 茂 只野 | 薬草入浴剤の製造方法 |
CN110062760A (zh) * | 2016-10-10 | 2019-07-26 | 约翰霍普金斯大学 | 抗d,d-转肽酶和l,d-转肽酶的抗细菌剂 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB207453A (en) * | 1923-03-10 | 1923-11-29 | Thomas Ford | Improvements in automatic stapling, label tacking machines and the like |
US4168314A (en) * | 1977-11-17 | 1979-09-18 | Merck & Co., Inc. | 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid |
EP0003960B1 (de) * | 1978-02-02 | 1983-06-29 | Ciba-Geigy Ag | 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate |
JPS5625110A (en) * | 1978-12-18 | 1981-03-10 | Bristol Myers Co | Antibacterial |
IL59081A0 (en) * | 1979-01-10 | 1980-05-30 | Schering Corp | 2-penem compounds and a method for preparing them |
EP0024832B1 (de) * | 1979-08-10 | 1985-03-13 | Beecham Group Plc | Beta-Lactam-Antibiotika, ihre Herstellung, sie enthaltende pharmazeutische Zusammensetzung und ihre Herstellung |
JPS56142282A (en) * | 1980-03-10 | 1981-11-06 | Sankyo Co Ltd | Penem-3-carboxylic acid derivative and its preparation |
SE8101464L (sv) * | 1980-03-10 | 1981-09-11 | Sankyo Co | 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning |
JPS572292A (en) * | 1980-06-06 | 1982-01-07 | Sankyo Co Ltd | Production of penem-3-carboxylic derivative |
GB2083462B (en) * | 1980-08-16 | 1984-05-02 | Beecham Group Ltd | 2-thiopenem derivatives |
US4347183A (en) * | 1981-02-02 | 1982-08-31 | Schering Corporation | Process for the synthesis of penems and carbapenems |
IT1190842B (it) * | 1981-06-30 | 1988-02-24 | Erba Farmitalia | Via di sintesi di derivati otticamente attivi dell'acido 2-penem-3-carbossilico |
JPS588084A (ja) * | 1981-07-08 | 1983-01-18 | Takeda Chem Ind Ltd | (6r)−置換−(5r)−ペネム−3−カルボン酸誘導体およびその製造法 |
DE3277696D1 (en) * | 1981-07-15 | 1987-12-23 | Sumitomo Pharma | Carboxylic beta-lactam compounds and the preparation thereof |
JPS5835190A (ja) * | 1981-08-25 | 1983-03-01 | Sankyo Co Ltd | ペネム−3−カルボン酸誘導体 |
CA1190236A (en) * | 1981-10-23 | 1985-07-09 | Edward J.J. Grabowski | Antibiotic synthesis |
US4411906A (en) * | 1981-11-25 | 1983-10-25 | Schering Corporation | (5R,6S,8R)-6-(1-Hydroxyethyl)-2-(2-fluoroethylthio)-penem-3-carboxylates |
EP0087792A1 (de) * | 1982-03-01 | 1983-09-07 | Merck & Co. Inc. | 6-Substituierte 2-carbamimidoyl-pen-2-em-3-Carbonsäure, Verfahren zu ihrer Herstellung und sie enthaltende antibiotische Zusammensetzungen |
-
1983
- 1983-11-21 AT AT83111615T patent/ATE112778T1/de not_active IP Right Cessation
- 1983-11-21 EP EP89113483A patent/EP0345827A1/de not_active Withdrawn
- 1983-11-21 DE DE3382761T patent/DE3382761T2/de not_active Expired - Fee Related
- 1983-11-21 EP EP83111615A patent/EP0110280B1/de not_active Expired - Lifetime
- 1983-11-24 FI FI834305A patent/FI834305A/fi not_active Application Discontinuation
- 1983-11-24 AU AU21676/83A patent/AU575545B2/en not_active Ceased
- 1983-11-24 DK DK538183A patent/DK166152C/da not_active IP Right Cessation
- 1983-11-24 GR GR73061A patent/GR81289B/el unknown
- 1983-11-24 PT PT77712A patent/PT77712B/pt not_active IP Right Cessation
- 1983-11-24 NZ NZ206389A patent/NZ206389A/en unknown
- 1983-11-25 JP JP58221927A patent/JPH0631254B2/ja not_active Expired - Lifetime
- 1983-11-25 NO NO834331A patent/NO165073C/no unknown
- 1983-11-25 IL IL70327A patent/IL70327A0/xx unknown
- 1983-11-25 KR KR1019830005593A patent/KR880002512B1/ko not_active IP Right Cessation
- 1983-11-28 HU HU834073A patent/HU194889B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3382761D1 (de) | 1994-11-17 |
PT77712B (en) | 1986-05-12 |
JPH0631254B2 (ja) | 1994-04-27 |
DK538183A (da) | 1984-05-30 |
KR880002512B1 (ko) | 1988-11-26 |
IL70327A0 (en) | 1984-02-29 |
AU575545B2 (en) | 1988-08-04 |
EP0345827A1 (de) | 1989-12-13 |
FI834305A (fi) | 1984-05-30 |
EP0110280B1 (de) | 1994-10-12 |
AU2167683A (en) | 1984-06-07 |
DE3382761T2 (de) | 1995-03-09 |
NO165073B (no) | 1990-09-10 |
NZ206389A (en) | 1986-10-08 |
ATE112778T1 (de) | 1994-10-15 |
NO834331L (no) | 1984-05-30 |
EP0110280A1 (de) | 1984-06-13 |
DK538183D0 (da) | 1983-11-24 |
FI834305A0 (fi) | 1983-11-24 |
JPS59108789A (ja) | 1984-06-23 |
GR81289B (de) | 1984-12-11 |
KR840006807A (ko) | 1984-12-03 |
PT77712A (en) | 1983-12-01 |
DK166152B (da) | 1993-03-15 |
DK166152C (da) | 1993-08-09 |
HU194889B (en) | 1988-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO165073C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6-hydroxyalkyl-2-(substituert)thio-penem-3-carboxylsyrer | |
HU9600962D0 (en) | Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases | |
ATE181919T1 (de) | Camptothecinderivat und dessen verwendung als antitumormittel | |
AU7368391A (en) | 2,8-dioxabicyclo(3,2,1)octane derivatives and culture of MF5453 for their production and use as antihypercholesterolemics | |
KR960704890A (ko) | 이미다조[1,2-a] 피리딘의 알콕시알킬 카르바메이트 (ALKOXY ALKYL CARBAMATES FROM IMIDAZO [1,2-a] PYRIDINES) | |
KR880001677A (ko) | β-락탐 화합물, 그의 제조 방법, 이를 함유하는 세균 감염성 질병 치료용 약제 및 그의 합성을 위한 중간체 | |
IL86080A (en) | Substituted alkoxy-2-alkyl-indan and 1,2,3,4-tetrahydro-naphthol,process for the preparation thereof and pharmaceutical compositions comprising the same | |
ATE5070T1 (de) | Z-2-acylamino-3-monosubstituierte propensaeuren und deren ester und salze und verfahren zu ihrer herstellung. | |
ES8104323A1 (es) | Un procedimiento para obtener 2,6-diaminonebularinas | |
MA21450A1 (fr) | Nouveaux derives antiviraux puriniques et leur procede de preparation. | |
IE832310L (en) | Vinylthioacetamido oxacephalosporin derivatives | |
WO1993004059A1 (en) | 4-acylaminoimidazole derivative | |
EP0050671A4 (de) | THIAZOL(3,2-a)PYRIMIDIN-DERIVATE, VERFAHREN ZU DEREN HERSTELLUNG UND ARZNEIMITTEL, DIE DIESE ENTHALTEN. | |
FI910231A0 (fi) | Diastereoselektiv framstaellning av fosfinatestrar. | |
NO304652B1 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive platina(II)-komplekser | |
AU686104B2 (en) | Substituted amidinonaphthyl ester derivatives | |
PT86613A (pt) | Process for preparing 6-beta(substituted)-(s)-hydroxymethyl-pe-nicillanic acids and derivatives thereof | |
YU45013B (en) | Process for obtaining derivatives of (r) and (s)-6-(1-acyl-1-hydroximethyl)penicilanic acid | |
JPS55102584A (en) | Preparation of alpha-sulfobenzylpenicilin and its salt | |
NO169488C (no) | Fremgangsmaate for fremstilling av nye terapeutiske aktive1,2-ditol-3-oner | |
FR2710058B1 (fr) | Procédé de préparation de sels organiques de cuivre et de zinc de haute pureté. | |
TH13040EX (th) | คาร์บาพีเนม ซึ่งมีหมู่เฟนิลที่ถูกแทนที่ด้วย หมู่คาร์บอกซิ, กรรมวิธีสำหรับเตรียมสารเหล่านั้น สารขั้นกลางการใช้เป็นสารปฏิชีวนะ |